We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Prostate Cancer Blood Test Found Equally Effective Across Ethnic Groups

By LabMedica International staff writers
Posted on 07 Aug 2024
Print article
Image: The Stockholm3 prostate cancer test produces significantly better results than the current PSA standard (Photo courtesy of 123RF)
Image: The Stockholm3 prostate cancer test produces significantly better results than the current PSA standard (Photo courtesy of 123RF)

Stockholm3, a prostate cancer test that analyzes a combination of protein and genetic markers from a blood sample using an algorithm, has been shown to predict the likelihood of clinically significant cancer with greater accuracy than the conventional prostate-specific antigen (PSA) test. Research involving over 90,000 men indicates that Stockholm3 outperforms PSA, helping to avoid unnecessary MRIs and biopsies, and identifying serious cancers even in men with low or normal PSA levels. Historically, these studies primarily involved a predominantly White Scandinavian population, casting doubt on their applicability globally. Now, a new study has confirmed that Stockholm3 is equally effective across diverse ethnic backgrounds and continues to outperform the PSA standard significantly.

The study, conducted by researchers at Karolinska Institutet (Stockholm, Sweden) where the Stockholm3 blood test was developed, involved more than 2,000 men from 17 clinics, with ethnic backgrounds including 16% Asian, 24% African-American, 14% Latin American, and 46% White American. Each participant was recommended for a prostate biopsy based on elevated PSA scores, abnormal rectal exams, concerning MRI results, or other suspicious clinical signs. Before undergoing a biopsy, each subject had a blood sample taken for the Stockholm3 test, performed without knowledge of the biopsy outcomes.

The findings published in The Journal of Clinical Oncology showed that clinically relevant prostate cancer was detected in 29% of participants, with a slightly higher incidence among African Americans and a lower one among Asians. Importantly, the Stockholm3 test was shown to potentially reduce unnecessary biopsies by 45% (673 compared to 1,226), while maintaining effectiveness in detecting all clinically significant cases across different ethnicities. The researchers assert that these findings address critical concerns and anticipate that this evidence will facilitate broader adoption of the Stockholm3 test globally.

“The study demonstrates that the Stockholm3 test is just as effective on an ethnically mixed group as it is on a White, Swedish population,” said the study’s lead author Hari T. Vigneswaran, doctor and PhD student at Karolinska Institutet.

Related Links:
Karolinska Institutet

Gold Member
Dengue Virus Test
LINEAR Dengue-CHIK
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Chagas Rapid Test
OnSite Chagas Ab Combo Rapid Test
New
1,5-anhydroglucitol (1,5-AG) Assay
1,5-anhydroglucitol (1,5-AG) Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Industry

view channel
Image: Roche has expanded its digital pathology open environment with more than 20 AI algorithms (Photo courtesy of Roche)

Roche Expands Digital Pathology Open Environment with Integration of Advanced AI Algorithms from New Collaborators

Roche (Basel, Switzerland) has expanded its digital pathology open environment by integrating over 20 advanced artificial intelligence (AI) algorithms from eight new collaborators. These strategic collaborations... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.